Oncoscience Gmbh
Oncoscience is a Germany based privately-owned biopharmaceutical company founded in 2001 to advance the development of novel products for the treatment of orphan indications in oncology. Oncoscience has the exclusive rights for the anti-EGFR monoclonal antibody Nimotuzumab, in the European Union and the surrounding area (in total 46 countries). Oncoscience is committed to further developing oncology products in Europe to address oncological diseases for which the unmet medical need is high and for which effective and safe therapy is urgently needed. To learn more about Oncoscience, visit
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
4
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Oncoscience Gmbh
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- ER
Erika Rendra
Scientific Affairs Manager · Science
EmailPhone - RE
Robert Ellerson
Managing Director · General Business & Management
EmailPhone
Showing 2 of 3 verified contacts
Top roles at Oncoscience Gmbh
3 distinct titles indexed · top 3 shown.
- 1it manager
- 1managing director
- 1scientific affairs manager
Sign up to unlock all 3 contacts at Oncoscience Gmbh
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Oncoscience Gmbh
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.